During the second quarter of 2025, apixaban prices in the USA reached 44,617 USD/MT in June. The market witnessed a steady increase, supported by consistent demand for cardiovascular and stroke prevention treatments, alongside stable procurement patterns across pharmaceutical manufacturers nationwide. https://www.imarcgroup.com/apixaban-pricing-report